What is the market doing?
What the tape says about SNDX
Syndax Pharmaceuticals, Inc. is +26% over the past year while the S&P 500 is +20%: 5.3 points ahead of the market.
+26%
1-year return · S&P 500 +20%
- vs 200-day average
- −3.2%
vs 200-day average · below trend, but not far
- RSI (14)
- 52
RSI (14) · neutral
- Below its 52-week high
- 21%
Below its 52-week high
Details›
- Last close2026-09-08
- $19.95
- 1 monthS&P 500 −0.30%
- +0.94%
- 1 yearS&P 500 +20%
- +26%
- 5 yearsS&P 500 +85%
- +28%
- vs 50-day average$20.25
- −1.5%
- 52-week high
- $25.15
- 52-week low
- $13.11
- Annualised volatility
- 62%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$781K
| Year | Return |
|---|---|
| 2026 (year to date) | −5.0% |
| 2025 | +59% |
| 2024 | −39% |
| 2023 | −15% |
| 2022 | +16% |
| 2021 | −1.6% |
| 2020 | +153% |
| 2019 | +97% |
| 2018 | −49% |
| 2017 | +22% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +3.9% |
| Feb | 10 | 7 of 10 | +8.0% |
| Mar | 10 | 6 of 10 | +5.4% |
| Apr | 10 | 3 of 10 | +0.36% |
| May | 10 | 3 of 10 | −2.8% |
| Jun | 10 | 6 of 10 | +2.6% |
| Jul | 11 | 6 of 11 | +1.4% |
| Aug | 11 | 6 of 11 | +9.5% |
| Sep | 11 | 6 of 11 | −2.5% |
| Oct | 10 | 2 of 10 | −7.8% |
| Nov | 10 | 6 of 10 | +4.6% |
| Dec | 10 | 5 of 10 | +3.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.